Cleviprex Approval History
- FDA approved: Yes (First approved August 1st, 2008)
- Brand name: Cleviprex
- Generic name: clevidipine butyrate
- Dosage form: Injectable Emulsion
- Company: The Medicines Company
- Treatment for: High Blood Pressure
Cleviprex (clevidipine) is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.
Development History and FDA Approval Process for Cleviprex
|Aug 4, 2008||The Medicines Company’s Cleviprex Receives FDA Approval|
|Sep 14, 2007||FDA Accepts NDA Filing for Cleviprex (Clevidipine Butyrate Injectable Emulsion) for the Treatment of Acute Hypertension|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.